Kallmes David F, Schweickert Patricia A, Marx William F, Jensen Mary E
Department of Radiology, University of Virginia Health Services, Charlottesville, VA 22908, USA.
AJNR Am J Neuroradiol. 2002 Aug;23(7):1117-20.
Vertebroplasty performed in the mid- and upper thoracic spine presents technical challenges that differ from those in the lower thoracic and lumbar region. We herein report results of percutaneous vertebroplasty for treatment of painful, osteoporotic compression fractures in the mid- and upper thoracic spine.
Retrospective chart review identified vertebroplasty treatments performed for painful osteoporotic compression fractures at T4-T8. The following were catalogued: percentage of vertebral body compression, needle size, surgical approach, clinical outcome, volume of cement injected, and complications.
Sixty-three vertebral bodies were treated in 41 patients. Mean percentage of compression was 44%. Bipediculate injections were used in 12 (19%) of 63 treatment levels, and unipediculate injections were used in 51 (81%) of treatments (75 injections performed). Eleven-gauge needles were used for 55 (73%) of the 75 injections, and 13-gauge needles were used for 20 (27%). Clinical follow-up was available for 76% of the patients. Mean pre- and postoperative pain intensity was 9.7 +/- 1.0 and 1.7 +/- 1.9, respectively (P <.0001). Mean pre- and postoperative medication scores were 3.4 +/- 0.7 and 1.7 +/- 1.7, respectively (P =.075). Fracture involving the pedicle used for needle access was noted in one (1.3%) of 75 injections; this pedicle had been traversed using a 13-gauge needle. Staphylococcus epidermidis infection occurred in one case. No cases of pneumothorax were noted.
Transpedicular vertebroplasty is readily and safely performed using 11-gauge needles in the mid- and upper thoracic regions, yielding excellent pain relief and low complication rates.
中胸段和上胸段椎体成形术面临的技术挑战与下胸段和腰段不同。我们在此报告经皮椎体成形术治疗中胸段和上胸段疼痛性骨质疏松性压缩骨折的结果。
通过回顾性病历审查确定了对T4 - T8节段疼痛性骨质疏松性压缩骨折进行的椎体成形术治疗。记录以下内容:椎体压缩百分比、穿刺针规格、手术入路、临床结果、注入骨水泥量和并发症。
41例患者共治疗63个椎体。平均压缩百分比为44%。63个治疗节段中有12个(19%)采用双侧椎弓根注射,51个(81%)治疗节段(共进行75次注射)采用单侧椎弓根注射。75次注射中有55次(73%)使用11号穿刺针,20次(27%)使用13号穿刺针。76%的患者有临床随访数据。术前和术后平均疼痛强度分别为9.7±1.0和1.7±1.9(P <.0001)。术前和术后平均用药评分分别为3.4±0.7和1.7±1.7(P =.075)。75次注射中有1次(1.3%)出现穿刺针进入的椎弓根骨折,该椎弓根使用的是13号穿刺针。发生1例表皮葡萄球菌感染。未发现气胸病例。
在中胸段和上胸段使用11号穿刺针可轻松、安全地进行经椎弓根椎体成形术,能有效缓解疼痛且并发症发生率低。